International Stem Cell CORP (ISCO) › Net IncomeInternational Stem Cell CORP (ISCO) — Net IncomeAnnual figures by period end, from SEC filings.2006-12-31: -$6.58M2007-12-31: -$6.07M2008-12-31: -$6.57M2009-12-31: -$8.51M2010-12-31: -$12.72M2011-12-31: -$9.17M2012-12-31: -$9.83M2013-12-31: -$10.48M2014-12-31: -$12.48M2015-12-31: -$2.63M2016-12-31: -$1.08M2017-12-31: -$6.07M2018-12-31: -$2.13M2019-12-31: -$4.26M2020-12-31: -$2.72M2021-12-31: -$899.0K2022-12-31: -$331.0K2023-12-31: -$131.0K2024-12-31: -$209.0K2025-12-31: -$418.0K-$418.0K2006-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31-$418.0K—2026-03-30From 2025-01-012024-12-31-$209.0K—2026-03-30From 2024-01-012023-12-31-$131.0K—2025-03-28From 2023-01-012022-12-31-$331.0K—2024-03-28From 2022-01-012021-12-31-$899.0K—2023-03-30From 2021-01-012020-12-31-$2.72M—2022-03-29From 2020-01-012019-12-31-$4.26M—2021-03-30From 2019-01-012018-12-31-$2.13M—2020-06-01From 2018-01-012017-12-31-$6.07M—2019-04-15From 2017-01-012016-12-31-$1.08M—2018-04-09From 2016-01-012015-12-31-$2.63M—2017-03-31From 2015-01-012014-12-31-$12.48M—2016-03-30From 2014-01-012013-12-31-$10.48M—2015-03-30From 2013-01-012012-12-31-$9.83M—2014-03-17From 2012-01-012011-12-31-$9.17M—2013-03-26From 2011-01-012010-12-31-$12.72M—2013-03-26From 2010-01-012009-12-31-$8.51M—2013-03-26From 2009-01-012008-12-31-$6.57M—2013-03-26From 2008-01-012007-12-31-$6.07M—2013-03-26From 2007-01-012006-12-31-$6.58M—2013-03-26From 2006-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)